Role of small intestinal bacterial overgrowth in functional gastrointestinal disorders

Journal of Neurogastroenterology and Motility

Volumn 22, Issue 1, 2016, Pages 3-5

  Choi, Chang Hwan ^a   Chang, Sae Kyung ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CARBON DIOXIDE; GLUCOSE; HYDROGEN; LACTULOSE; METHANE; XYLOSE;

ARTICLE; BACTERIAL LOAD; BACTERIAL OVERGROWTH; DYSPEPSIA; HUMAN; HYDROGEN BREATH TEST; IRRITABLE COLON;

EID: 84955155645     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm15196     Document Type: Article

References (15)

1. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, MearinF, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
3. Spiller R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome:mechanisms and practical management. Gut 2007;56:1770-1798.
4. Ford AC, Spiegel BM, Talley NJ, Moayyedi P. Small intestinal bacterialovergrowth in irritable bowel syndrome: systematic review and metaanalysis. Clin Gastroenterol Hepatol 2009;7:1279-1286.
5. Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinalbacterial overgrowth: meaningful association or unnecessary hype. WorldJ Gastroenterol 2014;20:2482-2491.
6. Quigley EM. Small intestinal bacterial overgrowth: what it is and what itis not. Curr Opin Gastroenterol 2014;30:141-146.
7. Lin HC. Small intestinal bacterial overgrowth: a framework for understandingirritable bowel syndrome. JAMA 2004;292:852-858.
8. Srivastava D, Ghoshal U, Mittal RD, Ghoshal UC. Associations betweenIL-1RA polymorphisms and small intestinal bacterial overgrowthamong patients with irritable bowel syndrome from India. NeurogastroenterolMotil 2014;26:1408-1416.
9. Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth:maximizing test accuracy. Clin Gastroenterol Hepatol 2014;12:1964-1972.
10. Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indicationsof H2-breath testing in gastrointestinal diseases: the Rome ConsensusConference. Aliment Pharmacol Ther 2009;29(suppl 1):1-49.
11. Shimura S, Ishimura N, Mikami H, et al. Small intestinal bacterial overgrowthin patients with refractory functional gastrointestinal disorders. JNeurogastroenterol Motil 2016;22:60-68.
12. Menees SB, Maneerattannaporn M, Kim HM, Chey WD. The efficacyand safety of rifaximin for the irritable bowel syndrome: a systematicreview and meta-analysis. Am J Gastroenterol 2012;107:28-35.
13. Ghoshal UC, Kumar S, Mehrotra M, Lakshmi C, Misra A. Frequencyof small intestinal bacterial overgrowth in patients with irritable bowelsyndrome and chronic non-specific diarrhea. J Neurogastroenterol Motil2010;16:40-46.
14. Goebel-Stengel M, Stengel A, Schmidtmann M, Voort I, Kobelt P, Mönnikes H. Unclear abdominal discomfort: pivotal role of carbohydratemalabsorption. J Neurogastroenterol Motil 2014;20:228-235.
15. Spiegel BM. Questioning the bacterial overgrowth hypothesis of irritablebowel syndrome: an epidemiologic and evolutionary perspective. ClinGastroenterol Hepatol 2011;9:461-469.